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Available online 1 April 2014Abstract Within the field of dental tissue engineering, the establishment of adequate tissue vascularization is one of the
most important burdens to overcome. As vascular access within the tooth is restricted by the apical foramen, it is of major
importance to implement effective vascularization strategies in order to recreate viable components of teeth and periodontal
tissues. However, while the current regenerative approaches focus on the use of dental stem cells (DSCs), little is known about
these cells and their ability to promote angiogenesis. Therefore, the present study aimed to elucidate the paracrine angiogenic
properties of postnatal DSCs, in particular dental pulp stem cells (DPSCs), stem cells from the apical papilla (SCAPs) and dental
follicle precursor cells (FSCs). An antibody array, together with RT-PCR and ELISA, pointed out the differential expression
of pro-angiogenic as well as anti-angiogenic factors by cultured DSCs and human gingival fibroblasts (HGF-1). Despite the
secretion of proliferation-promoting factors, DSCs caused no notable increase in the proliferation of human microvascular
endothelial cells (HMEC-1). With regard to other aspects of the angiogenic cascade, DPSCs, SCAPs and HGF-1 significantly
promoted endothelial migration in a transwell migration assay. DPSCs also had a pronounced effect on endothelial
tubulogenesis, as was shown by an in vitro Matrigel™ assay. In the last part of this study, a chorioallantoic membrane assay
demonstrated a sustained pro-angiogenic impact of DPSCs and SCAPs in an in vivo setting. Collectively, these data indicate a
predominant pro-angiogenic influence of DPSCs and SCAPS in vitro and in vivo in comparison to FSCs, suggesting that both stem
cell populations could potentially promote the vascularization of regenerated dental tissues.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Dental pulp tissue is a highly innervated and vascularized
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).appears to be very vulnerable to external insults such as
trauma, chemical irritation or microbial infection (Huang,
2009). Despite the relatively high success rate of traditional
endodontic treatment, which involves the replacement of
the diseased or necrotic pulp by gutta percha, treatment
of immature teeth in particular, remains to be a challenge
as any factor that interferes with normal pulp physiology
may conflict with the completion of root development
(Hargreaves et al., 2013; Huang, 2008). Arrested root
development following pulp necrosis can lead to weakenings an open access article under the CC BY-NC-ND license
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fractures and thereby reducing its survival rate (Andreasen
et al., 2002; Cvek, 1992; Nosrat et al., 2014). Recently,
more regenerative endodontic procedures have been intro-
duced, involving root canal disinfection followed by the
induction of a blood clot in order to promote the release of
growth factors and to attract residing stromal cells (Huang,
2008; Nosrat et al., 2014). In addition, the use of appropriate
scaffolds in combination with angiogenesis-promoting growth
factors such as vascular endothelial growth factor (VEGF) and
basic fibroblast growth factor (bFGF) has also been proposed
and tested in animal models, although the nature of the
regenerated tissues in the latter approach is often unclear due
to its reliance on cell homing (Huang et al., 2013; Kim et al.,
2010; Mullane et al., 2008; Suzuki et al., 2011). Furthermore,
an often recurring concern in revitalization/cell homing
approaches to regenerate pulp tissue is the size of the
apex needed to allow proper revascularization, as vascular
supply within the tooth is limited by the apical foramen
(Huang et al., 2013). Multiple studies suggest a higher rate
of pulp revascularization and healing with apical sizes
between 1.1 and 1.5 mm (Andreasen et al., 1995; Kling
et al., 1986). However, a recent study of Iohara et al.
indicated the regeneration of pulp tissue in canals with only
0.7 mm apices when using a stromal cell-based method
(Iohara et al., 2011). Stromal cells with similar surface
characteristics as BMSCs can be found in numerous tissues
within the human body, such as adipose tissue, umbilical cord,
tendons and also teeth (Arana et al., 2013; Bi et al., 2007;
Huang et al., 2009; Kim et al., 2013). Over a decade ago,
Gronthos et al. were the first to report the presence of a stem
cell population within the dental pulp (Gronthos et al., 2000).
Besides dental pulp stem cells (DPSCs), dental tissues also
harbor other stromal cells such as stem cells from the apical
papilla (SCAPs) and dental follicle precursor cells (FSCs)
(Morsczeck et al., 2005; Sonoyama et al., 2008). These cells
can be relatively easy isolated from human third molars, a
procedure which involves little discomfort for the patient
compared to bone marrow aspiration (Hilkens et al., 2013;
Huang et al., 2009; Vanhelleputte et al., 2003). Numerous
studies already suggested the potential role of DSCs in the
repair of diseased and damaged dental tissues, as they are
capable of forming dentin–pulp complexes and periodontal
tissues in vivo (Huang et al., 2009; Huang et al., 2008; Iohara
et al., 2013; Rosa et al., 2013; Sonoyama et al., 2008). Apart
from their well-known role in generating calcified tissues,
little is known about the angiogenic properties of DSCs.
With regard to DPSCs, a number of studies mentioned the
expression of paracrine angiogenic factors such as VEGF, bFGF
and platelet-derived growth factor (PDGF) under basal
conditions and after injury or hypoxia (Aranha et al., 2010;
Nakashima et al., 2009; Tran-Hung et al., 2008; Tran-Hung
et al., 2006). Furthermore, a couple of studies have indicated
the in vitro differentiation capacity of DPSCs into endothelial
or pericyte-like cells, which could indicate the potential
incorporation of these cells into newly formed blood vessels
although proof of true functionality is limited at this stage
(d'Aquino et al., 2007; Karbanova et al., 2011; Marchionni et
al., 2009). Although SCAPs and FSCs are considered to bemore
immature dental stem cell populations residing in strongly
vascularized tissues, literature merely indicates their expres-
sion of endostatin, bFGF and angiogenesis-regulatingtranscription factors such as hypoxia-inducible factor 1 alpha
(HIF1A) (Guo et al., 2013; Huang et al., 2009). Despite their
expression of angiogenic factors, the effects of both dental
stem cell populations on endothelial cell behavior and blood
vessel formation have not yet been described. Within the oral
environment, an additional cell population with potential
angiogenic properties can be found, namely gingival fibro-
blasts. In certain inflammatory and pathological conditions
human gingival fibroblasts (HGF) have been known to secrete
angiogenic factors such as urokinase (uPA), monocyte chemo-
tactic protein-1 (MCP-1), interleukin 8 (IL-8) and VEGF (Ogura
et al., 2001; Okada et al., 2009; Suthin et al., 2003).
Furthermore, these cells are capable of promoting the
proliferation of human umbilical cord vein endothelial cells
(HUVECs) (Okada et al., 2009). In order to potentiate any
therapeutic application of DSCs in dental tissue engineering, a
more elaborate angiogenic profiling is required. In the present
study, the paracrine angiogenic properties of DSCs and HGF
are further elucidated by determining the angiogenic expres-
sion profile at mRNA and protein level, after which the impact
of these cells on endothelial proliferation, migration and
tube formation is assessed in vitro. Finally, a chorioallantoic
membrane (CAM) assay is performed to evaluate the potential
of DSCs and HGF to induce blood vessel formation in vivo.Materials and methods
Cell culture
Dental tissues were obtained with informed consent from
patients (15–20 years of age) undergoing extraction of third
molars for orthodontic or therapeutic reasons at Ziekenhuis
Maas en Kempen, Bree, Belgium. Written informed consent of
patients below the age of 18 was obtained via their guardians.
This study was approved by the medical ethical committee
from Hasselt University. Immediately after extraction, dental
follicles and apical papillae were gently removed from the
teeth with forceps. The pulp tissue was obtained by means of
forceps after mechanically fracturing the teeth with surgical
chisels. Dental tissues were rinsed with Minimal essential
medium, alpha modification (αMEM, Sigma-Aldrich, St. Louis)
supplemented with 100 U/ml Penicillin and 100 μg/ml Strep-
tomycin (Sigma), 2 mM L-glutamine (Sigma) (further referred
to as standard DSC culture medium) containing 10% FBS
(Biochrom AG, Berlin, Germany), after which dental stem cells
were isolated according to the explant method as described
previously by our group (Hilkens et al., 2013). Briefly, dental
tissues weremechanically minced into fragments of 1–2 mm3,
which were cultured in 6-well plates in standard DSC culture
medium, to allow cellular outgrowth. All DSCs were routinely
screened for the expression of the following markers: CD31
(negative), CD34 (negative), CD44, CD45 (negative), CD90,
CD105 and Stro-1 (data not shown). A human microvascular
endothelial cell line (HMEC-1) was purchased from the Center
of Disease Control and Prevention (Atlanta, GA). The cells
were cultured in MCDB 131 medium (Invitrogen, Carlsbad, CA)
supplemented with 100 U/ml Penicillin and 100 μg/ml Strep-
tomycin, 10 mM L-glutamine, 10% FBS, 10 ng/ml human
epidermal growth factor (hEGF, Gibco, Paisley, UK) and
1 μg/ml hydrocortisone (Sigma) (further referred to as
standard endothelial culture medium). Human gingival
780 P. Hilkens et al.fibroblasts (HGF-1, CRL-2014, ATCC, Molsheim Cedex, France)
were cultured inαMEM supplementedwith 100 U/ml Penicillin
and 100 μg/ml Streptomycin, 2 mM L-glutamine and 20% FBS
(further referred to as standard HGF-1 culture medium).
All cell cultures were maintained at 37 °C in a humidified
atmosphere containing 5% CO2. The culture medium was
changed every 2–3 days and all cultures were regularly
monitored with an inverted phase-contrast microscope
(Nikon, Eclipse TS100, Nikon Co., Shinjuku, Tokyo, Japan).
When reaching 80–90% confluence, cells were harvested
using 0.05% Trypsin/EDTA (Sigma) and sub-cultured for further
experiments.
Dental stem cell conditioned medium
DSCs andHGF-1 (passages 2–4)were seeded at 20,000 cells/cm2
in standard culture medium. After 24 h of culturing, the cells
were rinsed twice with phosphate buffered saline (PBS) and
the medium was replaced with standard DSC culture medium
containing 0.1% FBS. Following 48 h of incubation, the
conditioned medium was harvested and stored at −80 °C.
Antibody array
In order to identify which angiogenesis-related proteins are
secreted by DSCs and HGF-1, a general screening was
performed by means of a human angiogenesis antibody
array (Proteome profiler™, R&D Systems, Minneapolis, MN)
according to the manufacturer's instructions. Briefly, while
array membranes were blocking, conditioned medium of
DSCs and HGF-1 was incubated with a detection antibody
cocktail. Standard DSC culture medium supplemented with
0.1% FBS was incorporated as a negative control. After 1 h of
incubation, the sample/antibody mixture was added to the
array membranes for overnight incubation. After rinsing
the membranes, Streptavidin–HRP was added for 30 min
at room temperature. In order to visualize the results,
chemiluminescent reagents (ECL plus, GE Healthcare, Little
Chalfont, UK) were added to the array membranes as
described by the manufacturer. Afterwards, the membranes
were exposed to X-ray film during 2 min (optimal exposure
time). The visualized dots were quantified using Image J
Software complemented with a dot blot analyzer plug-in.
This assay was performed three times on matched samples of
three different donors. The results were validated by
reverse transcriptase polymerase chain reaction (RT-PCR)
and enzyme-linked immunosorbent assay (ELISA).
Reverse transcriptase polymerase chain reaction
DSCs and HGF-1 (passages 2–3) were seeded at 4000 cells/cm2
and 2000/cm2, respectively, in standard culture medium.
When reaching 80–90% confluence, the cells were recovered
using 0.05% Trypsin/EDTA and cell pellets were made. Total
RNA was extracted from the cell pellets as described by
the RNeasy Plus Mini Kit (Qiagen). After determining the
concentration and the purity of the isolated RNA by means of
a spectrophotometer (NanoDrop 2000, Thermo Scientific,
Pittsburgh, PA), 700 ng of RNA was reverse transcribed
into cDNA using the Reverse Transcription System (Promega,
Leiden, The Netherlands). cDNA was amplified throughRT-PCR according to the following protocol: initialization
(5 min, 94 °C), 35 cycles of denaturation (1 min, 95 °C),
annealing (1 min, primer-specific Tm) and elongation (45 s,
72 °C), and additional elongation (10 min, 72 °C), after which
the samples were cooled to 4 °C. Reaction mixtures (25 μl)
consisted of: 1 μM of each primer, 1× PCR buffer, 200 μM
dNTPs and 0.75 U of Taq polymerase (Roche Diagnostics,
Basel, Switzerland). All primers were provided by Eurogentec
S.A. and are listed in Table 1. Samples were separated on a
1.2% agarose gel and visualized bymeans of ethidiumbromide.
This reaction was performed on 6 different patient samples of
each cell population, of which 3 representative samples are
shown.
Enzyme-linked immunosorbent assay
In order to obtain a clear view of the concentration range
of secreted angiogenic factors, the following ELISAs
were performed on conditioned medium of DSCs and HGF-1
(passages 2–4) according to the manufacturer's instructions:
angiopoietin-1 (ANGPT1) (Raybiotech, Norcross, GA),
insulin-like growth factor binding protein 3 (IGFBP3)
(Raybiotech) and vascular endothelial growth factor (VEGF)
(Raybiotech). All ELISAs were conducted on at least 6
different patient samples of each cell population.
Immunofluorescent stainings
Immunofluorescent stainings were performed on dental
tissues (pulp, apical papilla and follicle) as well as DSCs. In
order to maximize the amount of available tissue, different
donors were used for whole tissue and cell isolation
purposes. Dental tissues were isolated as explained earlier
and fixed in 4% paraformaldehyde (PFA) at room tempera-
ture. After dehydration in graded ethanol, the tissues were
embedded in paraffin and serial sections of 7 μm were
made. Following deparaffinization and rehydration, antigen
retrieval was performed by boiling the tissue sections in 1×
citrate buffer (Dako, Glostryp, Denmark). After cooling
down, the tissue sections were blocked for 30 min at room
temperature using 10% normal donkey serum in PBS
(Millipore, Billerica, MA). With regard to the cellular
stainings, DSCs were seeded at 2500 cells/cm2 in standard
DSC culture medium on glass cover slips (12 mm, Menzel
GmbH, Braunschweig, Germany). When reaching 70–80%
confluency, the cells were fixed in 4% PFA at room
temperature. Before blocking the cells for 20 min with 10%
normal donkey serum, the cells were pretreated with 0.05%
Triton X-100 (Boehringer, Mannheim, Germany) in PBS for
30 min at 4 °C. Primary antibodies, namely mouse mono-
clonal anti-human VEGF (1:50; R&D Systems) and rabbit
polyclonal anti-human CD146 (1:50; Abcam, Cambridge, UK)
were added to incubate overnight at 4 °C. Matched isotype
controls were used as a negative control condition. After-
wards, the sections were washed and incubated with the
appropriate secondary antibodies, namely Alexa Fluor
555-labeled donkey anti-mouse antibody (1:500, Invitrogen)
and Alexa Fluor 488-labeled donkey anti-rabbit antibody
(1:500, Invitrogen), for 30 min at room temperature. The
specificity of the secondary antibody was verified by
omitting the primary antibody (data not shown). Following
Table 1








Angiogenin NM_001145.4 Forward CCT-GGG-CGT-TTT-GTT-GTT-GG 62.2 352
Reverse TGT-GGC-TCG-GTA-CTG-GCA-TG
Dipeptidyl peptidase IV NM_001935.3 Forward GGC-ACC-TGG-GAA-GTC-ATC-GGG-A 65.6 237
Reverse GGG-CAG-ACC-AGG-ACC-GGA-AC
Endothelin 1 NM_001955.4 Forward TTG-CCA-AGG-AGC-TCC-AGA-AAC-AGC 64 206
Reverse ACG-GAA-CAA-CGT-GCT-CGG-GA
Insulin-like growth factor binding
protein 3
NM_001013398.1 Forward TTG-CAC-AAA-AGA-CTG-CCA-AG 62 275
Reverse CAA-CAT-GTG-GTG-AGC-ATT-CC
Pentraxin 3 NM_002852.3 Forward TCC-CCA-TTC-AGG-CTT-TCC-TCA-GCA 65.2 277
Reverse ACG-GCG-TGG-GGT-CCT-CAG-TG
Pigment epithelial-derived factor NM_002615.5 Forward ATC-CAC-AGG-CCC-CAG-GAT-GCA-G 65.4 235
Reverse GCT-CGT-GCT-GGA-TCG-CAC-CC
Plasminogen activator inhibitor 1 NM_003256.3 Forward ATA-CTG-AGT-TCA-CCA-CGC-CC 62.1 320
Reverse GTG-GAG-AGG-CTC-TTG-GTC-TG
Tissue inhibitor of matrix
metalloproteinase 1
NM_003254.2 Forward GCT-TCT-GGC-ATC-CTG-TTG-TT TTT-GCA- 60 462
Reverse GGG-GAT-GG A-T A A-AC
Tissue inhibitor of matrix
metalloproteinase 4
NM_003256.3 Forward CAA-GAG-GTC-AGG-TGG-TAA 54 446
Reverse ACA-GCC-AGA-AGC-AGT-ATC
Thrombospondin 1 NM_003246.2 Forward CAG-GGC-TCC-TGT-CGC-TCT-CCA 56.6 793
Reverse ACA-TTC-TGC-AGC-ACC-CCC-TGG-AA
Urokinase NM_002658.3 Forward GCC-ATC-CCG-GAC-TAT-ACA-GA 59.7 417
Reverse AGG-CCA-TTC-TCT-TCC-TGG-GT
Housekeeping genes
p2-Microglobulin NM_004048.2 Forward CTC-ACG-TCA-TCC-AGC-AGA-GA 60 213
Reverse CGG-CAG-GCA-TAC-TCA-TCT-TT
p-Actin NM_001101.3 Forward AAA-TCT-GGC-ACC-ACA-CCT-TC 60 185
Reverse AGA-GGC-GTA-CAG-GGA-TAG-CA
781Angiogenic properties of dental stem cellscounterstaining cellular nuclei with 4′,6-diamidino-2-
phenylindole (DAPI, Invitrogen), all samples were incubated
with 0.1% Sudan Black in 70% ethanol in order to minimize
autofluorescence. Afterwards, DSCs and sections were
mounted with ‘fluorescent mounting medium’ (Dako).
Pictures were taken with a Nikon Eclipse 80i fluorescent
microscope equipped with a Nikon DS-2MBWc digital cam-
era. All stainings were performed three independent times
on different donor samples and representative pictures are
shown. Hematoxylin–eosin (H&E) stained tissue sections
were also included in order to clearly indicate the
perivascular region within the dental tissues.3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide assay
In order to determine the impact of DSCs and HGF-1 on the
proliferation of endothelial cells, a 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was
performed. HMEC-1 were seeded at 15,625 cells/cm2 in a
flat bottom 96-well plate in standard endothelial culture
medium. After 24 h of culturing, the cells were rinsed withPBS and incubated with either conditioned medium of DSCs
and HGF-1, standard DSC culture medium containing 10% FBS
(positive control) or standard DSC culture medium contain-
ing 0.1% FBS (negative control). All conditions were
performed in triplicate. Following 72 h of culturing, the
different conditions were replaced with 500 μg/ml MTT
(Sigma) in standard DSC culture medium containing 0.1%
FBS. After 4 h of incubation, the MTT solution was removed
and a mixture of 0.01 M glycine (Sigma) in DMSO (Sigma) was
added to dissolve the formed formazan. The absorbance was
measured at a wavelength of 540–550 nm with a Benchmark
microplate reader (Bio-Rad Laboratories, Hercules, CA). This
assay was repeated 4 independent times on a total of at least
9 patient samples of each stem cell population.Transwell migration assay
DSCs (passages 2–5) andHGF-1were seeded at 50,000 cells/cm2
in a 24-well plate in standard culture medium. After 24 h of
culturing, the cells were rinsed with PBS and incubated
with standard DSC culture medium containing 0.1% FBS to
allow the secretion of angiogenic factors. The next day, tissue
782 P. Hilkens et al.culture inserts (ThinCert™, 8 μm pore size, Greiner Bio-One,
Frickenhausen, Germany) were seeded with HMEC-1 at
150,000 cells/cm2 in standard DSC culture medium containing
0.1% FBS and placed above the wells. Standard DSC culture
medium containing 10% FBS and 0.1% FBS was used as a
positive and negative control in the wells beneath. Following
24 h of incubation, transmigrated HMEC-1 were fixed with 4%
paraformaldehyde (PFA) at room temperature and stained
with 0.1% crystal violet in 70% ethanol. Per insert, two repre-
sentative pictures were taken with an inverted phase-
contrast microscope (Nikon Eclipse TS100) equipped with a
ProgRes® C3 digital microscope camera (Jenoptik AG, Jena,
Germany). The amount of migration (expressed as mean area
percentage) was quantified using AxioVision software 4.6.3
(Carl Zeiss Vision, Aalen, Germany). This assay was indepen-
dently performed on at least 12 different patient samples of
each cell population.
Tube formation assay
In order to evaluate the effect of DSCs and HGF-1 on
tubulogenesis, a tube formation assay was performed. The
inner wells of an Angiogenesis μ-slide (Ibidi GmbH, Planegg/
Martinsried, Germany) were coated with growth factor-
reduced BD Matrigel™ Basement Membrane Matrix (BD
Biosciences, Franklin Lakes, NJ). After the matrix had set,
the outer wells of the μ-slide were seeded with a cell
suspension containing 5000 HMEC-1 and conditioned medium
of DSCs or HGF-1. Standard DSC culture medium containing
10% FBS and 0.1% FBS was used as a positive and negative
control, respectively. The cultures were maintained for 24 h
at 37 °C in a humidified atmosphere containing 5% CO2. The
next day, 2 representative pictures per well were taken with
an inverted phase-contrast microscope (Nikon Eclipse TS100)
equipped with a ProgRes® C3 digital microscope camera
(Jenoptik AG). Per picture, 5 blood vessels were measured
starting from themiddle of each branching point using Image J
Software. This assay was performed 5 independent times on
samples of 5 different donors.
Chorioallantoic membrane assay
A chorioallantoic membrane (CAM) assay was performed in
order to examine the angiogenic behavior of DSCs and HGF-1 in
an in vivo setting. Fertilized white leghorn chicken eggs (Gallus
gallus) were incubated for 3 days at 37 °C in a humidified
atmosphere. After 3 days (E3), 3–4 ml albumen was removed
from the eggs in order to detach the developing CAM from the
egg shell. A small opening was made in the shell, which was
covered afterwards with cellophane tape before the eggs were
returned to the incubator. Six days later (E9), the CAM was
incubated with Matrigel™ droplets containing 50,000 DSCs
(passages 3–4) or HGF-1. Pure Matrigel™ droplets were applied
as a negative control. Following 3 days of incubation (E12), the
eggs were opened and the CAM was carefully dissected out of
the eggs to assess angiogenesis. Pictures were taken with a
stereomicroscope (Wild M3Z Stereomicroscope, Heerbrugg,
Switzerland) equipped with a Nikon digital net camera DN100.
In order to quantify angiogenesis, two concentric circles (radii
1.5 mm and 2 mm) were drawn and intersecting blood vessels
were counted independently 2 times in a double-blind fashion.This assay was performed 4 independent times on samples of 4
different donors, leading to a total of at least 26 eggs per
experimental condition.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5
Software (GraphPad Software, La Jolla, CA). Data distribution
was assessed bymeans of a D'Agostino& Pearson normality test.
In the case of a Gaussian distribution, experimental groups
were compared using a one way ANOVA with a Tukey–Kramer
multiple comparison post-hoc test or a repeated measures
ANOVA with a Newman–Keuls post-hoc test. Non-parametric
data were compared with a Kruskall–Wallis test combined
with a Dunns post-hoc test. Differences were considered to
be statistically significant at p-values ≤0.05. All data were
expressed as mean ± standard deviation (s.d.).
Results
Angiogenic expression profile of DSCs
The first part of this study focused on the identification of
the angiogenic factors expressed by DSCs and HGF-1. In a
first stage, a general screening of conditioned medium was
performed using an antibody array. Dot blot analysis showed
the relative expression of a wide variety of angiogenic
proteins by DSCs as well as HGF-1 (Fig. 1A, arrays). The array
legend can be found in supplemental Fig. 1. The following
pro-angiogenic (green) and anti-angiogenic factors (red)
showed no real trends towards differential expression
between the different cell populations or displayed a
relatively low expression pattern and were validated by
RT-PCR: uPA, endothelin-1 (EDN1), dipeptidyl peptidase IV
(DPPIV), angiogenin (ANG), plasminogen activator inhibitor 1
(PAI-1), thrombospondin-1 (THBS1), tissue inhibitor of matrix
metalloproteinase 1 and 4 (TIMP1/4), pentraxin-3 (PTX3) and
pigment epithelium-derived factor (PEGF) (Fig. 1A, graph).
The entire graph can be found in supplemental Fig. 2.
Visualization by means of gel electrophoresis indicated a
variable expression of these factors between the different cell
populations as well as between the different patient samples.
Angiogenic factors of which the antibody array indicated a
trend towards differential expression (Fig. 1A, graph), namely
ANGPT1, IGFBP3 and VEGF, were validated through ELISA in
order to obtain a clear view of the range of the secreted
concentrations (Table 2). Analysis revealed no significant
differences between the different cell populations in terms of
ANGPT1 expression levels. With regard to the expression of
IGFBP3, FSCs secreted a significantly higher concentration
compared to DPSCs and SCAPs. DPSCs, on the other hand,
demonstrated notably higher levels of VEGF secretion in
comparison to the other cell populations (Fig. 1C). Since the
expression of angiogenic factors such as VEGF can be induced
by culture conditions (Potapova et al., 2007), an immunoflu-
orescent staining was carried out in order to evaluate the in
situ expression of this protein in dental tissues. Dental pulp,
as well as apical papilla and dental follicle showed positive
expression of VEGF throughout the whole tissue. Co-
expression with CD146 was also detected, in particular in
perivascular regions (Fig. 2A, white arrows). Cultured dental
Figure 1 Angiogenic expression profile of dental stem cells. A. Detection of protein spots on the array membrane. Pro-angiogenic factors (green) as well as anti-angiogenic factors
(red) were secreted in the conditioned medium of dental pulp stem cells (DPSCs), stem cells from the apical papilla (SCAPS), dental follicle precursor cells (FSCs) and human gingival
fibroblasts (HGF-1). Culture medium containing 0.1% fetal bovine serum (FBS) was used as a negative control condition. The graph shows relative levels of protein secretion by the
different cell populations. This assay was performed three times on matched samples of three different donors. B. Reverse transcriptase polymerase chain reaction. This assay was
performed on 6 different patient samples. Three representative samples are shown. C. Enzyme-linked immunosorbent assay. ELISAs were performed on conditioned medium of at least








Figure 2 Expression of VEGF in dental tissues and cultured dental stem cells. A. In situ expression of VEGF in all dental tissues
(dental pulp, apical papilla and dental follicle). Co-expression of VEGF and CD146 was mainly observed around the perivascular region
(white arrows). H&E stained sections were added to indicate the perivascular region (black arrow, PV). B. Co-expression of VEGF and
CD146 in dental pulp stem cells (DPSCs), stem cells of the apical papilla (SCAPs) and dental follicle precursor cells (FSCs). Negative
control: matched isotype control. This staining was performed three independent times of samples of three different donors.
Representative pictures are shown. Scale bars = 50 μm.
784 P. Hilkens et al.stem cells were also positive for VEGF expression as well as
CD146 (Fig. 2B).Functional analysis of the angiogenic potential of
DSCs in vitro
As angiogenesis is a well-orchestrated biological reaction,
involving a multitude of regulating factors, it is not only
important to determine which of these factors are secreted
by DSCs but also to assess the potential influence of DSCs on
the behavior of endothelial cells. Therefore, multiple in vitroassays were performed, mimicking the different steps of the
angiogenic process. One of the first events within the
angiogenic cascade comprises the proliferation of endothelial
cells. Hence, in a first stage the proliferation-stimulating
capacity of DSCs was tested by means of a MTT assay. After
incubating HMEC-1 with conditioned medium for 72 h, no
apparent difference in proliferation was detected compared
to the control conditions (Fig. 3).
During angiogenesis, endothelial cells also respond to
chemotactic stimuli in order to migrate towards the site
which requires vascular supply (Carmeliet, 2000). Accord-
ingly, the chemotactic potential of DSCs was evaluated using
Table 2
Range of secreted concentrations of angiogenic factors. * = p-value b 0.05; ** = p-value b 0.01.
Concentration (pg/ml)
Angiogenic factor DPSCs SCAPs FSCs HGF-1
Angiopoietin-1 7547 ± 2744 7S03 ± 3629 4296 ± 1380 3905 ± 1977
Insulin-like growth factor binding protein 3 656.7 ± 338.6 666.3 ± 330 1290 ± 601.4 (**) 1394 ± 166.2
Vascular endothelial growth factor 2403 ± 935 (*) 1482 ± 591.4 1482 ± 611.1 120.5 ± 82.73
785Angiogenic properties of dental stem cellsa transwell migration system, which involved 24 h incuba-
tion of HMEC-1 (seeded in a culture insert) with DSCs and
HGF-1 (seeded in the wells beneath) in order to induce
transmigration (Fig. 4A). In particular DPSCs, SCAPs and
HGF-1 caused a significant increase in endothelial cell
migration (Fig. 4A, graph).
With regard to tubulogenesis, a Matrigel™ assay was
applied to examine the effect of DSCs on endothelial tube
formation. Following 24 h of incubation, the conditioned
medium of DPSCs in particular induced a pronounced
increase in tubulogenesis compared to the negative control
situation. Furthermore, analysis indicated a significantly
higher impact of DPSC conditioned medium compared to
SCAPs and HGF-1, respectively (Fig. 4B).
Collectively, these data suggest a paracrine pro-angiogenic
effect of DSCs, in particular DPSCs and SCAPs, in vitro.
Angiogenesis in vivo
To confirm whether DSCs could sustain their paracrine
effects in an in vivo setting, a CAM assay was performed.
After 3 days of incubation, a characteristic spoke wheel
pattern was observed in all test samples, as the capillariesFigure 3 Cell proliferation assay. Endothelial proliferation
following 72 h of incubation with conditioned medium from
dental pulp stem cells (DPSCs), stem cells of the apical papilla
(SCAPs), dental follicle precursor cells (FSCs) and human
gingival fibroblasts (HGF-1). Negative control: culture medium
containing 0.1% fetal bovine serum (FBS). Positive control:
culture medium containing 10% FBS. The conditioned medium of
dental stem cells as well as human gingival fibroblasts was not
able to increase endothelial proliferation, as compared to the
positive control medium. This assay was repeated 4 independent
times on at least 9 different patient samples.grew radially towards the different cell populations (Fig. 5A,
arrows). Representative pictures were taken and two
concentric circles were drawn to allow quantification of
intersecting blood vessels in a double-blind fashion. Com-
pared to the control condition, DPSCs and SCAPs caused a
significant increase in blood vessel count, while this was not
the case for FSCs and HGF-1 (Fig. 5B).
Discussion
Within the human body, three mechanisms of blood vessel
formation can be distinguished, namely vasculogenesis,
arteriogenesis and angiogenesis. In particular angiogenesis,
i.e. the sprouting of new capillaries from pre-existing blood
vessels, is the most predominant mechanism in the adult
body (Carmeliet, 2000). Capillary sprouting does not only
play an important role in physiological processes, but it also
is a determining factor for the survival of transplanted cells
and tissues. Especially within the field of dental tissue
engineering, the establishment of adequate tissue vascular-
ization is an important burden to overcome, as dental blood
supply is restricted to the apical foramen (Huang, 2009;
Huang et al., 2013). Multiple studies already indicated apical
size as a key factor in pulpal healing and vascularization
(Andreasen et al., 1995; Kling et al., 1986). Next to the size
of the root apex, the nature of the regenerated tissue is also
of major importance, an aspect which is rather ambiguous
in current revitalization/cell homing-based regenerative
procedures (Huang et al., 2013; Kim et al., 2010; Mullane
et al., 2008; Suzuki et al., 2011). However, recent studies
indicated the regeneration of organized and vascularized
dental tissues after dental stem cell transplantation, even
when the size of the apical foramen was limited to 0.7 mm
(Iohara et al., 2013; Iohara et al., 2008; Rosa et al., 2013).
Therefore, the main focus of this study was to compare the
paracrine angiogenic potential of postnatal DSCs, in partic-
ular DPSCs, SCAPs and FSCs, together with a HGF-1 cell line
as an additional population from the oral environment with
potential angiogenic properties.
In a first part of this study, the presence of angiogenic
proteins in the conditioned medium of DSCs and HGF-1 was
determined by means of an antibody array. This general
screening demonstrated the differential secretion of multi-
ple angiogenesis-related factors by the studied cell popula-
tions. In-depth expression analysis at mRNA level indicated
the expression of angiogenesis-stimulating (uPA, EDN1,
DPPIV and ANG) as well as angiogenesis-inhibiting (PAI-1,
THBS1, TIMP1/4, PTX3 and PEGF) factors by DSCs and HGF-1.
A subset of these factors, namely uPA, EDN1 and THBS1,
were previously reported in primary rat and human cultures
Figure 4 Impact of dental stem cells on endothelial migration and tube formation. A. Representative endothelial transmigration following 24 h of incubation with dental pulp stem
cells (DPSCs), stem cells of the apical papilla (SCAPs), dental follicle precursor cells (FSCs) and human gingival fibroblasts (HGF-1). Negative control: culture medium containing 0.1%
fetal bovine serum (FBS). Positive control: culture medium containing 10% FBS. Scale bars = 200 μm. The graph shows the mean area percentage of endothelial migration. DPSCs,
SCAPs and HGF-1 caused a significant increase of endothelial migration as compared to the negative control medium. This assay was independently repeated on at least 12 different
patient samples. B. Representative endothelial tube formation following 24 h of incubation with conditioned medium of DPSCs, SCAPs, FSCs and HGF-1. Negative control: culture
medium containing 0.1% FBS. Positive control: culture medium containing 10% FBS. Scale bars = 200 μm. The graph shows the average endothelial tube length (μm). DPSC conditioned
medium significantly increased endothelial tube formation. DPSCs significantly differed from SCAPs and HGF-1 regarding their impact on tubulogenesis. This assay was performed 5







Figure 5 Chorioallantoic membrane assay. A. Representative vascularization of the chorioallantoic membrane (CAM) following
3 days of incubation with growth factor-reduced Matrigel™ containing dental pulp stem cells (DPSCs), stem cells of the apical papilla
(SCAPs), dental follicle precursor cells (FSCs) and human gingival fibroblasts (HGF-1). Matrigel™ alone was used as a negative control
condition. A characteristic spoke wheel pattern was observed in all test conditions (arrows). Scale bars = 2 mm. B. Average
number of blood vessels. DPSCs and SCAPs significantly increased the number of capillaries intersecting both circles. This assay was
performed 4 independent times on matched samples of 4 different donors, leading to a total of at least 26 eggs per experimental
condition. * = p-value b 0.05.
787Angiogenic properties of dental stem cellsof gingival fibroblasts (Chin et al., 2009; Koh et al., 2004;
Ogura et al., 2001). A number of studies also indicated the
(inflammation-induced) expression of other angiogenic
factors by primary HGF-1, such as MCP-1, bFGF, ANGPT2,
CXCL12 and CXCR4, some of which were also minimally
detected in our antibody array (Hosokawa et al., 2005; Koh
et al., 2004; Okada et al., 2009). At the protein level, ELISA
showed the secretion of ANGPT1, IGFB3 and VEGF by DSCs
and HGF-1. ANGPT1 primarily plays a role in tubulogenesis
and vessel stabilization, while IGFB3 is thought to have a
dual function; i.e. stimulation of angiogenesis on the one
hand by promoting endothelial motility and inhibition of
angiogenesis on the other hand by downregulating pro-
angiogenic factors such as VEGF and bFGF (Benini et al.,
2006; Granata et al., 2007; Liu et al., 2007). VEGF is a
well-known protein which serves many functions within
the angiogenic cascade, such as the regulation of vessel
permeability, the stimulation of endothelial proliferation
and migration, and the downregulation of endothelial
apoptosis (Distler et al., 2003). No significant differenceswere demonstrated between the different cell populations
in terms of ANGPT1 expression. However, VEGF was shown
to be secreted at substantially high levels by DPSCs, as
previously reported by others (Tran-Hung et al., 2008;
Tran-Hung et al., 2006). Earlier studies also mentioned the
inflammation-induced expression of VEGF by primary cul-
tures of HGF-1 (Hosokawa et al., 2005; Suthin et al., 2003).
In accordance with a previous report of Götz et al. which
highlighted the expression of the IGF system in human
permanent teeth, IGBP3 was secreted by all DSC popula-
tions, though at significantly higher concentrations by FSCs
(Gotz et al., 2006).
With regard to the functional analysis of DSCs and HGF-1,
several in vitro tests were performed with endothelial cells
(HMEC-1) to assess their influence on the different steps of the
angiogenic process. Despite the expression of multiple mito-
gens such as VEGF, EDN1, DPPIV and ANG, DSCswere not able to
increase the proliferation of HMEC-1. A potential explanation
for this discrepancy could be the concentration of the secreted
proliferation-stimulating factors, which was presumably too
788 P. Hilkens et al.low to cause a sustainable effect. Another explanation may lie
in the expression of proliferation-inhibiting factors, such as
PTX3 and THBS1; the actions of these proteins could be
predominant in comparison to the angiogenesis-promoting
factors and tip the angiogenic balance towards an inhibitory
state. In contrast, Iohara et al., demonstrated a significant
increase of human umbilical vein endothelial cell (HUVEC)
proliferation following incubation with conditioned medium of
porcine pulp-derived CD31− CD146− stem cells (Iohara et al.,
2008). However, besides considering the potential species-
related differences between swine and human, it also has to be
kept in mind that the aforementioned subset of DPSCs could
potentially display more pronounced angiogenic properties
than DPSCs in general (Nakashima et al., 2009). In comparison,
studies regarding the proliferation-stimulating capacity of
BMSCs yielded similar conflicting results. While Potapova et
al. and others mentioned a significant increase in HUVEC
proliferation caused by BMSCs, Gruber et al., demonstrated no
proliferation-promoting effect of BMSC conditioned medium
(Chen et al., 2008; Gruber et al., 2005; Kinnaird et al., 2004;
Potapova et al., 2007). However, the constitution of the
applied conditioned medium appears to play an important
role, as the addition of fetal bovine serum can increase the
expression of proliferation-stimulating factors such as VEGF and
in that way bias the outcome of the experiment (Potapova et
al., 2007). For that reason, the conditioned medium in this
study only contained 0.1% FBS in order to avoid artificial
upregulation of VEGF or other mitogens.
Another important aspect within the angiogenic cascade
is endothelial migration. Since the expression analysis
demonstrated that DSCs and HGF-1 express multiple factors
which are known to affect migration, such as ANGPT1, EDN1,
IGFBP3, uPA and VEGF, a transwell migration assay was
carried out to assess their chemotactic potential. Following
24 h of incubation, DPSCs, SCAPs and HGF-1 significantly
increased endothelial transmigration, while FSCs had no
substantial impact. Given the high secretion of IGFBP3 by
FSCs, the lack of a pronounced migration-stimulating effect
was rather unexpected. However, the aforementioned dual
role of IGFBP3 taken together with the lower secretion of
VEGF and ANGPT1 probably established suboptimal condi-
tions for endothelial migration. HGF-1 on the other hand,
display a secretion profile similar to FSCs in terms of VEGF,
IGFBP3 and ANGPT1 and do significantly enhance endothelial
migration. This discrepancy can be explained by the potential
contribution of other (yet to be identified) angiogenic factors
which influence endothelial migration. With regard to the
chemotactic properties of BMSCs, similar observations were
made by Potapova et al. and others, who mentioned a sig-
nificant increase in HUVEC transmigration caused by stromal
cell-conditioned medium (Gruber et al., 2005; Potapova
et al., 2007).
In terms of tubulogenesis, functional assays showed a
pronounced effect of DPSCs on endothelial tube formation,
an outcome which also differed significantly from SCAPs
and HGF-1. Earlier studies of Tran-Hung et al. and others,
reported a similar increase and stabilization of endothelial
tubular structures following direct co-culture of HUVECs and
DPSCs, indicating a more pericyte-like behavior of DPSCs
(Dissanayaka et al., 2012; Janebodin et al., 2013; Tran-Hung
et al., 2006). Human and murine BMSCs on the other hand,
are also capable of promoting endothelial tube formation,as was shown by a number of studies (Estrada et al., 2009;
Lin et al., 2012; Sorrell et al., 2009; Wu et al., 2007). Since
ANGPT1 and VEGF play an important role in the induction of
tubulogenesis, the aforementioned increase can probably be
explained by the angiogenic secretion profile of the dif-
ferent cell populations as DPSCs displayed a notably higher
VEGF secretion compared to SCAPs, FSCs and HGF-1.
In the last part of this study, a CAM assay was conducted in
order to determine the angiogenic properties of DSCs in an in
vivo setting. According to earlier reports of Laschke et al., the
CAM assay is an idealmodel to study vascular development due
to its capability to support the ingrowth of blood vessels and
its lack of a complete immune system which allows for the
assessment of xenografts without rejection (Laschke et al.,
2006). Following incubation with DSCs as well as HGF-1, a
characteristic spoke wheel pattern could be distinguished
caused by the radial ingrowth of blood vessels (Baiguera et al.,
2012). In particular DPSCs and SCAPs significantly enhanced
neoangiogenesis. In comparison, BMSCs were also found to
promote blood vessel ingrowth in a CAM assay, notwithstand-
ing the alteredmodel the authors applied (Gruber et al., 2005;
Oskowitz et al., 2011).
Despite the expression of several angiogenesis-inhibiting
factors such as TIMP, PAI-1, THBS1 and PTX3, these data
collectively suggest a predominant pro-angiogenic impact of
DSCs, and in particular DPSCs and SCAPs, in vitro and in vivo.Conclusion
This study was the first to describe the angiogenic properties
of SCAPs and FSCs in an in vitro and in vivo setting.
Furthermore, it compares three different dental stem cell
populations, namely DPSCs, SCAPs and FSCs, together with a
HGF-1 cell line with regard to their angiogenic expression
profile and impact on endothelial cell behavior in vitro and in
vivo. DSCs seemed to have a predominant pro-angiogenic
impact on endothelial migration and tube formation, in vitro
as well as in an in vivo set-up. Our results suggest a stronger
angiogenic profile and function of DPSCs and SCAPs in
comparison to FSCs and HGF-1, encouraging further investi-
gation of both of these stem cell populations as potential
therapeutic tools. The dental field can significantly benefit
from the angiogenic properties of DSCs, in particular in pulp
regeneration and whole tooth engineering, as vascular supply
is an important burden to overcome in these applications.Acknowledgments
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